FDA Approves New Treatment for Hemophilia – With Caveats

by KJ McElrath | Nov 17, 2017 | Pharmaceutical Industry |

Swiss pharmaceutical company Roche scored a victory this week as the FDA granted its approval for...

American College of Cardiology Revises Definition of High Blood Pressure Downward: is it Real, or is This a Ploy by Big Pharma to Increase Sales?

by KJ McElrath | Nov 16, 2017 | Pharmaceutical Industry |

Prior to last weekend, if your blood pressure was no more than 140/90, you were considered to be...

2018 National Defense Authorization Act Allows Defense Department to Sidestep the FDA – Is This a Good Idea?

by KJ McElrath | Nov 15, 2017 | Pharmaceutical Industry |

Over the Veteran’s Day weekend, Congress was busy finalizing the National Defense...

Could a Form of Electromagnetic Therapy Replace Antidepressant Medications?

by KJ McElrath | Nov 3, 2017 | Pharmaceutical Industry |

This could be bad news for Big Pharma, for which sales of antidepressant medications bring in...

Medical Researchers Have Identified a Third Type of Diabetes – Could Certain Prescription Medications be Responsible?

by KJ McElrath | Oct 31, 2017 | Pharmaceutical Industry |

Medical science has recognized a third form of diabetes – and Medical researchers in the U.K. are...

The Unusual Mushroom Called “Lion’s Mane” Might Have True Medical Benefits

by KJ McElrath | Oct 27, 2017 | Pharmaceutical Industry |

A little fungus known to science as hericium erinaceus – and more popularly as the “lion’s...